Money Lancer
← Equity: Sectoral-Pharma and Healthcare
Quant Mutual Fund
Quant Mutual Fund · Equity: Sectoral-Pharma and Healthcare

Quant Healthcare Fund - Growth Option - Regular Plan

The investment objective of the scheme is to seek long term capital appreciation by investing in equity/equity related instruments of companies from the healthcare sector. There is no assurance that the investment objective of the Scheme will be achieved.

EquityBenchmark · Nifty Healthcare TRITER · 3.13%Inception · 11-07-2023
NAV
₹17.40
-0.92% · as of 14-10-2026
Since inception
18.60%
CAGR
Benchmark (inception)
14.55%
CAGR
Fund size
₹431 Cr
AUM
Expense ratio
3.13%
29-09-2026
Performance

Returns vs benchmark & category

Since inception: +18.60% CAGR vs benchmark +14.55%.

Portfolio

Where the money is invested

Top holdings

TREPS 01-Jul-2026 DEPO 1021.73%
HFCL LIMITED EQ NEW F.V.RE.1/-10.76%
Zydus Wellness Ltd9.44%
ASTER DM HEALTHCARE LIMITED EQ8.96%
CONCORD BIOTECH LIMITED EQ NEW FV RE.1/-8.84%
Glenmark Pharmaceuticals Ltd8.70%
SMS PHARMACEUTICALS LIMITED EQ NEW FV Re.1/-8.15%
GLENMARK LIFE SCIENCES LIMITED EQ NEW FV Rs.2/-7.28%
Max Healthcare Institute Limited5.80%
Divis Laboratories Limited5.74%

Sector allocation

Healthcare50.81%
Telecommunication10.76%
Fast Moving Consumer Goods9.44%
Riskometer
LowVery High
Very High

What if you'd SIP'd here?

@ 18.6% p.a.
₹10,000
10 years
Projected value
₹34,93,802
Invested: ₹12,00,000
Gained: ₹22,93,802
Start this SIP →

Illustration based on fund's since-inception return. Past performance is not indicative of future returns.

Risk Analysis

How this fund manages risk

Fund manager
S
Sandeep Tandon, Sameer Kate, Sanjeev Sharma, Ankit Pande, Yug Tibrewal, Varun Pattani, Ayusha Kumbhat
Manager since fund inception data not available
ISIN & identifiers
AMFI code
151855
ISIN (Growth)
INF966L01CG3
ISIN (Div Re-inv)
—
Status
Open Ended Schemes
Peers

Other Equity: Sectoral-Pharma and Healthcare funds

Want a personalised recommendation?

Our team will tell you whether this fund fits your goals, allocation and risk profile — and suggest peers if it doesn't.

Chat with us